© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
March 03, 2021
Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin.
February 24, 2021
The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction.
February 22, 2021
Application to the FDA is based on results from a placebo-controlled trial showing a 15% decrease in body weight among those who are obese or overweight.
February 16, 2021
February 10, 2021
One of the new treatments available is a CAR-T cell therapy to treat relapsed or refractory large B-cell lymphoma.
February 09, 2021
Preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with the rheumatoid arthritis and ulcerative colitis medicine Xeljanz.
February 02, 2021
Aurinia’s Lupkynis, used in combination with a background immunosuppressive therapy regimen, is available now.
February 01, 2021
January 27, 2021
FDA approves first complete long-acting HIV-1 treatment